Regard Review 2026

AI clinical insights platform that reviews 100% of patient charts to support hospital documentation, diagnosis capture, and revenue integrity workflows.

Regard is an enterprise AI clinical insights platform for hospitals and health systems that reviews patient charts, drafts clinical documentation, and recommends diagnoses inside clinical workflows, with sales-led custom pricing rather than a public self-serve price, making it best suited to organizations evaluating documentation quality, clinician efficiency, and revenue integrity impact at scale. The platform is positioned around full-chart review rather than narrow note assistance: Regard says it reviews 100% of patient charts, uses EHR chart data to surface clinical evidence, and helps clinicians create more complete documentation before or during patient review. Its public product narrative emphasizes Proactive Documentation, which generates near-complete draft notes such as H&Ps and progress notes from the patient chart, and Max, an AI assistant described for diagnosing, care planning, and answering questions from the chart.

For hospital leaders, the core value proposition is the combination of clinical documentation support and diagnosis capture. Regard is not a consumer symptom checker or a general medical chatbot; it is built for enterprise hospital workflows involving hospitalists, CDI teams, revenue integrity teams, and health system IT stakeholders. Public materials describe diagnosis recommendations that clinicians can review and accept, and Regard states that clinicians have accepted 1,000,000 recommended diagnoses. The company also highlights scribe workflows that combine chart-derived insights with documentation support, plus an impact calculator that models assumptions around DRG upgrades, denial reduction, and documentation efficiency.